SI0817637T1 - Synergistic combinations of zidovudine, 1592u89 and 3tc - Google Patents

Synergistic combinations of zidovudine, 1592u89 and 3tc

Info

Publication number
SI0817637T1
SI0817637T1 SI9630494T SI9630494T SI0817637T1 SI 0817637 T1 SI0817637 T1 SI 0817637T1 SI 9630494 T SI9630494 T SI 9630494T SI 9630494 T SI9630494 T SI 9630494T SI 0817637 T1 SI0817637 T1 SI 0817637T1
Authority
SI
Slovenia
Prior art keywords
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
SI9630494T
Other languages
English (en)
Slovenian (sl)
Inventor
David Walter Barry
Clair Martha Heider Glaxo Wellcome Inc. St.
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0817637(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of SI0817637T1 publication Critical patent/SI0817637T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cephalosporin Compounds (AREA)
SI9630494T 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc SI0817637T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
EP96911953A EP0817637B1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc

Publications (1)

Publication Number Publication Date
SI0817637T1 true SI0817637T1 (en) 2002-10-31

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630494T SI0817637T1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc

Country Status (35)

Country Link
US (1) US6417191B1 (cs)
EP (1) EP0817637B1 (cs)
JP (1) JP2954357B2 (cs)
KR (1) KR100542536B1 (cs)
CN (1) CN1103593C (cs)
AP (1) AP652A (cs)
AT (1) ATE220551T1 (cs)
AU (1) AU715213B2 (cs)
BR (3) BRPI9607851B8 (cs)
CA (1) CA2216634C (cs)
CZ (1) CZ295940B6 (cs)
DE (3) DE122005000029I2 (cs)
DK (1) DK0817637T3 (cs)
EA (1) EA000626B3 (cs)
EE (1) EE04047B1 (cs)
ES (1) ES2179193T3 (cs)
FR (1) FR05C0022I2 (cs)
GE (1) GEP20022647B (cs)
HU (1) HU224010B1 (cs)
IL (1) IL117727A (cs)
LU (1) LU91171I2 (cs)
MX (1) MX9707316A (cs)
MY (1) MY115461A (cs)
NL (1) NL300195I2 (cs)
NO (2) NO313787B1 (cs)
NZ (1) NZ306419A (cs)
OA (1) OA10616A (cs)
PL (1) PL187085B1 (cs)
PT (1) PT817637E (cs)
RO (1) RO117995B1 (cs)
SI (1) SI0817637T1 (cs)
SK (1) SK283825B6 (cs)
TR (1) TR199701074T1 (cs)
UA (1) UA60293C2 (cs)
WO (1) WO1996030025A1 (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9903249A3 (en) * 1996-06-25 2001-04-28 Glaxo Group Ltd Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
CA2289655A1 (en) * 1997-05-17 1998-11-26 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
KR20080032014A (ko) 2003-01-14 2008-04-11 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
MXPA05010081A (es) 2003-03-24 2005-11-23 Hoffmann La Roche Bencil-piridazinonas como inhibidores de transcriptasa inversa.
NZ546873A (en) 2003-10-24 2010-09-30 Immunaid Pty Ltd Method of analysing immune system cycling to monitor and/or treat diseases characterised by the production of regulator T cells
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
JP2009515826A (ja) 2005-10-19 2009-04-16 エフ．ホフマン−ラ ロシュ アーゲー フェニル−アセトアミドｎｎｒｔ阻害剤
EP2089384B1 (en) 2006-12-13 2015-08-05 F. Hoffmann-La Roche AG 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
JP5467870B2 (ja) * 2007-02-09 2014-04-09 アルファファーム ピーティーワイ リミテッド 異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
DK2435825T3 (en) 2009-05-27 2015-10-19 Biotempus Ltd Modes for medical care
MX2012008774A (es) 2010-01-27 2012-08-17 Glaxosmithkline Llc Terapia antiviral.
EP3038607A2 (en) 2013-08-29 2016-07-06 Teva Pharmaceutical Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
WO2015155673A1 (en) 2014-04-08 2015-10-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN112430250A (zh) 2014-08-12 2021-03-02 莫纳什大学 定向淋巴的前药
CN108137482B (zh) 2015-09-08 2024-03-15 莫纳什大学 定向淋巴的前药
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
AU2018324037A1 (en) 2017-08-29 2020-04-16 Monash University Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
WO2021159021A1 (en) 2020-02-05 2021-08-12 Puretech Lyt, Inc. Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
SK279262B6 (sk) 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je
EP0639971B1 (en) * 1992-05-13 1999-09-22 The Wellcome Foundation Limited Therapeutic combinations
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
WO1997049410A1 (en) 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
HUP9903249A3 (en) 1996-06-25 2001-04-28 Glaxo Group Ltd Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
ES2179193T3 (es) 2003-01-16
EA000626B3 (ru) 2016-04-29
AP9701089A0 (en) 1997-10-31
GEP20022647B (en) 2002-03-25
EP0817637B1 (en) 2002-07-17
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
AU5497296A (en) 1996-10-16
FR05C0022I2 (cs) 2005-10-21
CA2216634C (en) 2004-07-20
CZ309097A3 (cs) 1998-05-13
NO313787B1 (no) 2002-12-02
NO2005014I1 (no) 2005-06-06
JP2954357B2 (ja) 1999-09-27
EE04047B1 (et) 2003-06-16
JPH10511682A (ja) 1998-11-10
KR100542536B1 (ko) 2006-03-23
IL117727A (en) 1999-11-30
HUP9801571A3 (en) 2001-04-28
KR19980703420A (ko) 1998-11-05
FR05C0022I1 (cs) 2005-06-10
US6417191B1 (en) 2002-07-09
LU91171I2 (fr) 2005-07-04
NO974510L (no) 1997-09-29
CZ295940B6 (cs) 2005-12-14
AU715213B2 (en) 2000-01-20
AP652A (en) 1998-06-19
MX9707316A (es) 1997-11-29
EE9700240A (et) 1998-04-15
NO2005014I2 (no) 2008-02-11
HK1009401A1 (en) 1999-09-10
DE122005000029I1 (de) 2005-10-06
SK129597A3 (en) 1998-07-08
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
IL117727A0 (en) 1996-07-23
DE69622386T2 (de) 2003-02-13
UA60293C2 (uk) 2003-10-15
RO117995B1 (ro) 2002-12-30
PL187085B1 (pl) 2004-05-31
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (en) 1996-10-03
CA2216634A1 (en) 1996-10-03
MY115461A (en) 2003-06-30
EA199700203A1 (ru) 1998-02-26
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
BRPI9607851B8 (pt) 2019-11-05
ATE220551T1 (de) 2002-08-15
BRPI9612992B1 (pt) 2020-08-04
EA000626B1 (ru) 1999-12-29
PL322532A1 (en) 1998-02-02
EP0817637A1 (en) 1998-01-14
DE122005000029I2 (de) 2006-04-27
HU224010B1 (hu) 2005-04-28
NO974510D0 (no) 1997-09-29
BR9607851A (pt) 1998-07-21
LU91171I9 (cs) 2018-12-28
BR9607851B1 (pt) 2009-01-13
DK0817637T3 (da) 2002-11-11
NL300195I2 (nl) 2005-11-01
CN1103593C (zh) 2003-03-26
OA10616A (en) 2001-03-15
CN1185110A (zh) 1998-06-17

Similar Documents

Publication Publication Date Title
HUP9801571A3 (en) Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9507130D0 (en) Hair treatment composition
GB9521125D0 (en) Cosmetic composition
ZA966814B (en) Clear cosmetic gel composition.
AU4603096A (en) Skin revitalizing makeup composition
AU7427498A (en) Hair treatment compositions
ZA964733B (en) Ob protein compositions and methods
AU5721798A (en) Human mage-like protein
ZA968250B (en) Cosmetic composition.
GB9511938D0 (en) Cosmetic composition
PL329404A1 (en) Chimeric isoprenoidic synthases and their application
GB9803642D0 (en) Hair treatment composition
AU4480697A (en) Human nm23-like protein
AU4899497A (en) Human p2x purinoreceptor
AU9260998A (en) Hair treatment compositions
ZA963697B (en) Clear cosmetic stick composition.
AU7216898A (en) Hair treatment compositions
AUPN499895A0 (en) Hair treatment composition
AU7470494A (en) Human oxalyl-coa decarboxylase
AU3983899A (en) Human promonocyte associated protein: prmnc
IL120904A0 (en) 1-C-perfluoroalkyl glycosides their preparation and their uses
HUP9903098A3 (en) Combination comprising vx478, zidovudine and/or 1592u89 and pharmaceutical composition containing them
IL122686A0 (en) Benzylhydroxylamines their preparation and use
AU2436095A (en) Cloning, expression, and uses of human lactoferrin
AU7217396A (en) Hair extensions